MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-UK-08-0001793
Simpex Pharma Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹70.72 Cr
▲ 24% YoY
Net profit · FY 2025
₹5.18 Cr
Net margin 7.3%
EBITDA · FY 2025
₹10.37 Cr
EBITDA margin 14.7%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹2.5 Cr
Issued & subscribed
Open charges
₹12 Cr
Satisfied ₹35.37 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
157
Provident fund records
About Simpex Pharma Private Limited
Data last updated:
Simpex Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 March 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33112DL1997PTC085657. Its GSTIN is 07AABCS7865B1ZC (Delhi). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹2.5 Cr. It is led by directors including Naresh Santhanam and Ajay Kumar Mishra.
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 302 3rd Floor, Ansal Tower 38, New Delhi, Delhi, India – 110019.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.72 Cr, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹5.18 Cr (net margin 7.3%) and EBITDA of ₹10.37 Cr (EBITDA margin 14.7%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years and 27% over five years.
The company has about 157 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Simpex Pharma. As per MCA filings, the company has open charges of ₹12 Cr and satisfied charges of ₹35.37 Cr on record. Court records list 5 cases involving the company, including 2 filed by the company and 3 filed against it; 2 cases are pending. The company has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹14.99 Cr; the latest was in October 2018. Its 5 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Momentum Biotech Private Limited with revenue of ₹71.34 Cr. The company has 7 MSME Form 1 returns on record between 2018 and 2024, listing 60 overdue payments to 34 micro and small suppliers.
Simpex Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-08-0001793). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website simpexpharma.com.
Company details
CIN U33112DL1997PTC085657
Registration Number 085657
Incorporation Date 07 March 1997
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 23 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-08-0001793
Recognitions & Rankings of Simpex Pharma
Contact details
Simpex Pharma Private Limited's registered office is in New Delhi, Delhi. Its website is simpexpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressFlat No – 302 3rd Floor, Ansal Tower 38, New Delhi, Delhi, India – 110019
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Simpex Pharma Private Limited, buy the company report.
Comprehensive company report
Simpex Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Simpex Pharma operates one associated brand: Simpex Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of medicines in India. | simpexpharma.com |
Business activity
The main business activity of Simpex Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Simpex Pharma Private Limited, buy the company report.
Financials of Simpex Pharma Private Limited
FY 2025 filings availableSimpex Pharma Private Limited reported revenue of ₹70.72 Cr (up 24% YoY) for FY 2025.
Revenue · FY 2025
₹70.72 Cr ▲ 24%
Net profit · FY 2025
₹5.18 Cr margin 7.3%
EBITDA · FY 2025
₹10.37 Cr margin 14.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 35%
5 years · compounded
▲ 27%
EBITDA CAGR growth
1 year
▲ 42%
3 years · compounded
▲ 42%
5 years · compounded
▲ 82%
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 24% growth in the latest year. EBITDA rose 42% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.18 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.7% | ||||
| Net Profit Margin | 7.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Simpex Pharma Private Limited, buy the company report.
Board of directors of Simpex Pharma Private Limited
Simpex Pharma has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naresh Santhanam | Director | 15 Feb 2010 | 16 Years 8 Months | Current |
| Ajay Kumar Mishra | Director | 06 Apr 2010 | 16 Years 7 Months | Current |
| Piyush Kumar Singh | Director | 02 Jan 2020 | 6 Years 10 Months | Current |
Peer comparison
Simpex Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Momentum Biotech Private Limited | ₹71.34 Cr (FY 2025) | 147.0% | Jaipur, Rajasthan, India | |||
| Synnat Pharma Private Limited | ₹71.34 Cr (FY 2024) | 12.0% | Hyderabad, Telangana, India | |||
| Sanjivani Paranteral Limited | ₹71.31 Cr (FY 2025) | 30.0% | Mumbai, Maharashtra, India | |||
| Simpex Pharma Private Limitedthis company | ₹70.72 Cr (FY 2025) | ₹5.18 Cr | 7.3% | 24.0% | 157 | New Delhi, Delhi, India |
| Jaahnavee Lifesciences Private Limited | ₹70.16 Cr (FY 2025) | 17.0% | Hyderabad, Telangana, India | |||
| Aneta Pharmaceuticals Private Limited | ₹70.12 Cr (FY 2025) | 671.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Simpex Pharma Private Limited, buy the company report.
Auditor
Simpex Pharma Private Limited is audited by Kashyap Sikdar & Co. for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Kashyap Sikdar & Co. | FY 2024 | 016253N |
Shareholding
The shareholding of Simpex Pharma Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Simpex Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12 Cr
Satisfied charges
₹35.37 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 Jun 2025 | 101122672 | Others | ₹12 Cr | Open | |
| 10 Jan 2022 | 100531986 | Others | ₹9.95 Cr | Satisfied | |
| 14 Apr 2011 | 10287786 | Corporation Bank | ₹5.42 Cr | Satisfied | |
| 21 Oct 2009 | 10182336 | Corporation Bank | ₹10 Cr | Satisfied | |
| 01 Sep 2009 | 10181318 | Corporation Bank | ₹10 Cr | Satisfied |
To see the full charge records of Simpex Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Simpex Pharma Private Limited has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹14.99 Cr; the latest was in October 2018.
Total deals
5
Funding rounds
3
Secondary share transfers
2
Disclosed funding
₹14.99 Cr
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Oct 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2008 | Funding round | ₹10 Cr | Investors: Baylake Finance S.A, an individual |
| Mar 2008 | Funding round | ₹4 Cr | Investors: 4 individuals |
| Mar 2007 | Funding round | ₹98.8 Lakh | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Simpex Pharma Private Limited has 5 court cases on record: 2 filed by Simpex Pharma, 3 filed against it. 2 cases are pending and 3 are disposed.
Total cases
5
Filed by the company
2
Filed against the company
3
Pending
2
Disposed
3
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 3 | 2 | 2 |
| District courts | 2 | 1 | 0 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South East, Delhi | Criminal case | Filed by the company against Molekule India Pvt Ltd Ors | Disposed |
| High Court of Uttarakhand | Court case (CLR) | Filed against the company by an individual | Pending |
| High Court of Uttarakhand | Court case (CLR) | Filed by the company against an individual | Pending |
| District court, Pauri Garhwal, Uttarakhand | Court case (Small Cause Court suits) | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (CRL.M.C.) | Filed against the company by an individual | Disposed |
To see the full case history of Simpex Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Simpex Pharma Private Limited was last rated by Crisil on 16 May 2016.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 16 May 2016 |
To see the full credit ratings and regulatory alerts of Simpex Pharma Private Limited, buy the company report.
MSME payment delays
Simpex Pharma Private Limited has 7 MSME Form 1 returns on record between 2018 and 2024, listing 60 overdue payments to 34 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 34)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Kalapi Print Pack LLP | |||
| Ideal Cures Private Limited | |||
| Spincotech Systems LLP | |||
| an individual supplier | |||
| Omega Printopack Private Limited |
To see the full MSME payment records of Simpex Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Simpex Pharma Private Limited has a workforce of 157 employees on its EPFO records as of Sep 23, 2025, across 1 active EPFO establishment.
Employee count
157
Active EPFO establishments
1
Employee growth
6.08%
GST
Simpex Pharma has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCS7865B1ZC | Delhi | Active | 01 Jul 2017 |
| 05AABCS7865B1ZG | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Simpex Pharma Private Limited, buy the company report.
Recent activity
Simpex Pharma Private Limited has 13 board changes on record since 2010: 3 appointments and 10 cessations. The latest: Piyush Kumar Singh ceased to be Additional Director on 31 Dec 2020.
AGM
Simpex Pharma Private Limited last Annual general meeting of members was held on 23 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 12.00 Cr registered on 19 Jun 2025 with Charge ID 101122672 was modified on 05 Aug 2025.
Charges
A charge registered on 10 Jan 2022 via Charge ID 100531986 with Others was fully satisfied on 07 Jul 2025.
Charges
A charge with Others amounted to Rs. 12.00 Cr with Charge ID 101122672 was registered on 19 Jun 2025.
Filing
Simpex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge with Others of Rs. 9.95 Cr registered on 10 Jan 2022 with Charge ID 100531986 was modified on 01 Aug 2024.
Charges
A charge with Others amounted to Rs. 9.95 Cr with Charge ID 100531986 was registered on 10 Jan 2022.
Charges
A charge registered on 14 Apr 2011 via Charge ID 10287786 with Corporation Bank was fully satisfied on 23 Jun 2021.
Ceased
Piyush Kumar Singh ceased to be Additional Director.
Charges
A charge registered on 21 Oct 2009 via Charge ID 10182336 with Corporation Bank was fully satisfied on 13 Feb 2020.
Appointed
Piyush Kumar Singh was appointed as Director.
Ceased
Sheetal Prasad Singh ceased to be Director.
16 earlier events are in the company report.
Frequently asked questions
Simpex Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 March 1997 (29+ years old) and is registered under CIN U33112DL1997PTC085657.
Simpex Pharma has 3 current directors:
- Naresh Santhanam - Director
- Ajay Kumar Mishra - Director
- Piyush Kumar Singh - Director
The latest financial statements of Simpex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Simpex Pharma is 07AABCS7865B1ZC, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 05AABCS7865B1ZG (Uttarakhand).
The CIN (Corporate Identification Number) of Simpex Pharma is U33112DL1997PTC085657. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Simpex Pharma has 5 court cases on record: 2 filed by the company and 3 filed against it. 2 are pending. Most are in the high courts.
Simpex Pharma was incorporated on 07 March 1997, making it 29+ years old. It is registered with the Registrar of Companies, Delhi.
Simpex Pharma has 5 deals on record (3 funding rounds, 2 secondary share transfers), with disclosed funding of ₹14.99 Cr; the latest was in October 2018.
The peers of Simpex Pharma by revenue are Momentum Biotech Private Limited, Synnat Pharma Private Limited, Sanjivani Paranteral Limited, Jaahnavee Lifesciences Private Limited, Aneta Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Piyush Kumar Singh ceased to be Additional Director on 31 Dec 2020. Piyush Kumar Singh was appointed as Director on 02 Jan 2020. Sheetal Prasad Singh ceased to be Director on 02 Jan 2020. Simpex Pharma has 13 board changes on record in total.
Yes, Simpex Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-UK-08-0001793).
Simpex Pharma has 7 MSME Form 1 returns on record between 2018 and 2024, listing 60 overdue payments to 34 micro and small suppliers. The latest return was filed on 27 Apr 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages